(CARE) CareCapital
Summary
Trade long or short on this share now through an Interactive Investor Spread Bet or CFD
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Headline | Source | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||||||||||
| 31-01-12 | RNS |
|||||||||||||||||
|
RNS Number : 5120W CareCapital Group plc 31 January 2012 31 January 2012
CARECAPITAL GROUP PLC ("CareCapital" or "the Company")
Result of Annual General Meeting
CareCapital plc (AIM: CARE) announces that at the Company's Annual General Meeting held today all resolutions were duly passed. The resolutions passed were:
Ordinary Business 1. To receive the report of the directors, the auditor's report and the audited financial statements for the period ended 31 December 2010.
2. To re-appoint Paul Quentin Cullum Stacey as a director of the Company who retires in accordance with the Company's Articles of Association and who, being eligible, offers himself for re-appointment.
3. To re-appoint Donald Baladasan as a director of the Company who retires in accordance with the Company's Articles of Association and who, being eligible, offers himself for re-appointment.
4. To re-appoint PKF (UK) LLP as auditors of the Company to hold office from the conclusion of this meeting until the conclusion of the next general meeting at which accounts are laid before the Company.
5. To authorise the Directors to determine the remuneration of the auditors.
Special Business 6. That the articles of association produced to the meeting and initialled by the Chairman of the meeting for the purposes of identification (the "Articles of Association") be and are hereby adopted as the articles of association of the Company in substitution for and to the exclusion of the Company's existing articles of association.
7. That the existing memorandum of association of the Company be amended by the deletion of paragraphs 4.1, 4.2 and 6.
8. THAT the Directors be and are hereby generally and unconditionally authorised for the purposes of section 551 of the Companies Act 2006 ("the Act"), to exercise all the powers of the Company to allot shares in the Company and/or to grant rights to subscribe for, or to convert any securities into, shares in the Company, provided that such authority shall be limited to the allotment of Ordinary Shares of £0.01 each in the capital of the Company ("Ordinary Shares") and/or the grant of rights to subscribe for or to convert any securities into Ordinary Shares up to an aggregate nominal amount of £1,406,005 (the equivalent of up to 140,600,500 Ordinary Shares), this authority to expire on the earlier of fifteen months from the date of the passing of this resolution or the conclusion of the next Annual General Meeting of the Company to be held in 2012 unless previously renewed, varied or revoked by the Company in general meeting, save that the Company may before such expiry make any offer or agreement which would or might require shares in the Company to be allotted and/or rights to subscribe for or to convert any securities into shares in the Company to be granted after such expiry and the Directors may allot shares in the Company, or grant rights to subscribe for or to convert any securities into shares in the Company, in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.
9. THAT, subject to the passing of Resolution 8 above, in substitution for all previous powers to the extent unused, the Directors be and are hereby unconditionally empowered pursuant to sections 570 and 571 of the Act to allot equity securities (as defined in section 560 of the Act) pursuant to the authority granted to the Directors pursuant to Resolution 8 above as if section 561 of the Act did not apply to any such allotment, provided that this power shall be limited to:
9.1 the allotment of equity securities in connection with a rights issue, open offer or equivalent offer in favour of the holders of Ordinary Shares and such other equity securities of the Company as the Directors may determine in which such holders are offered the right to participate in proportion (as nearly as may be) to their respective holdings of such equity securities or in accordance with the rights attached thereto but subject to such exclusions or other arrangements as the Directors may consider necessary or expedient in connection with shares representing fractional entitlements or on account of either legal or practical problems arising in connection with the laws of any territory, or of the requirements of any recognised regulatory body or stock exchange in any territory;
9.2 other than pursuant to sub-paragraph 9.1 above, the allotment of equity securities up to an aggregate nominal amount of £1,406,005 (the equivalent of up to 140,600,500 Ordinary Shares),
and this power shall expire on the earlier of fifteen months from the date of passing of this resolution and upon the conclusion of the next Annual General Meeting of the Company to be held in 2012 unless previously renewed, varied or revoked by the Company in general meeting, save that the Company may before such expiry make any offer or agreement which would or might require equity securities to be allotted after such expiry and the Directors may allot equity securities in pursuance of any such offer or agreement as if the power conferred hereby had not expired.
-ends-
For further information, please visit www.carecapital.co.uk or contact:
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||
| 31-01-12 | RNS |
|||||||||||||||||
|
RNS Number : 4339W CareCapital Group plc 31 January 2012 31 January 2012
CARECAPITAL GROUP PLC ("CareCapital", "the Group" or "the Company")
Annual General Meeting - Trading Update
CareCapital plc (AIM: CARE) will provide the following Trading Update to the Company's shareholders at its AGM to be held in London today:
"As already approved by shareholders, we sold our entire German portfolio on 9 November 2011 for an aggregate consideration of €27.35 million. This transaction has allowed us to substantially deleverage and will provide working capital to realise the value of our UK healthcare development pipeline.
The UK business model is to forward sell individual projects to third party landlords so that financial risk to the Group is minimized without forgoing or reducing development profits. Our confirmed pipeline today comprises developments in: Allesley, Coventry (a medical centre, pharmacy and related ancillary areas); a medical centre in Thingwell, West Wirral; a medical centre in Bishops Stortford and; four medical centres in Wales, of which Buckley and Swansea will see construction commence this year, that are part of the joint-venture with Gaufron Healthcare Limited. Construction is due to start this year on the projects in Wales and in Bishops Stortford. Taken together, these developments have a capital value to CareCapital on completion of £21.8 million, of which £14.6 million worth have been forward sold to investors. We anticipate completion of these developments within the next two years.
Following the disposal of our German business, the Group has taken the opportunity to rationalise its cost base to a level appropriate to its activities moving forward. In addition to losing the overheads associated with the German operations, we will not be renewing the lease (ending this month) on our head offices in central London. Together with other initiatives, the Board believes that this will save at least £250,000 in a full year.
In the opinion of the Directors, the Company's 28.75% shareholding in Advanced Proton Solutions (Holdings) Ltd ("APS") has the potential to be of significant value. Proton Beam Therapy is widely recognised worldwide as the most effective treatment for a variety of cancer conditions. There are currently 32 centres worldwide with a requirement, according to industry sources, of over 1,000 in the next 10 to 15 years. We have already secured planning approval for APS's first London based Proton Beam Therapy centre off Moorgate in the City of London - within easy access of a number of London's major hospitals. Once funding has been secured by APS, construction is scheduled to commence in 2012 and treatment of patients in 2014.
As a result of our involvement with APS, we have been approached by a number of providers of innovative, but proven, cancer treatments. We are currently evaluating these but believe that our activities in this area could form the basis of an exciting new healthcare division for CareCapital. We will provide a strategy update to shareholders in due course.
We are now, I believe, making good progress towards our objective of restoring value to shareholders."
Mike Sinclair Chairman 31 January 2012
For further information, please visit www.carecapital.co.uk or contact:
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||
| 16-01-12 | RNS |
|||||||||||||||||
|
RNS Number : 6465V CareCapital Group plc 16 January 2012 16 January 2012
CARECAPITAL GROUP PLC ("CareCapital" or "the Company") Holding in Company
CareCapital Plc (AIM: CARE), the healthcare real estate developer and owner, was notified on 16 January 2012 by Mr Trevor Brown that, following a purchase of shares on 16 January 2012, he has a beneficial interest in 21,545,668 ordinary shares in CareCapital, which represents 28.07% of the Company's current issued share capital. For further information please visit www.carecapital.co.uk or contact:
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||
| 21-12-11 | RNS |
|||||||||||||||||
|
RNS Number : 4274U AIM 21 December 2011
NOTICE
21/12/2011 1:00pm
RESTORATION OF TRADING ON AIM
CARECAPITAL GROUP PLC
The trading on AIM for the under-mentioned securities was temporarily suspended. The suspension is lifted from 21/12/2011 1:00pm, the company having published its annual audited accounts and half-yearly report.
Ordinary Shares of 1p each, fully paid (B16JQ76) (GB00B16JQ761)
If you have any queries relating to the above, please contact the company's nominated adviser on 020 7569 9650.
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||
| Result Pages: 1 | ||||
| Date/Time | Subject | Author | ||
|---|---|---|---|---|
| Wed 11:36 | ||||
|
|
||||
|
|
||||
|
Well, we seem to be moving again lets hope it's not just pump and dump. At least we should be on an even keel now with the debt gone but we dont have many assets left. Lets see if this change in direction works. I can see that it could but as ever we need to see some regular news flow. Something that CARE haven't been very good at over the past 5 years. Watch and wait. At least at the moment my loss is a loss and not a write off.
|
||||
| Thu 07:09 |
1 |
|||
|
|
||||
|
|
||||
|
Not THAT much cash in hand ? LOL You said £24m in cash against a market cap of £3m. They used all but approx. £1.5m to pay off debt.
Then you say it is STILL a booming DEBT free business. Well it certainly wasn't so how can it "STILL" be ?? Rampers like you Bel-end are two a penny on the stock market but it would certainly be a better place without you. Regards CTC |
||||
| 01-02-12 | ||||
|
|
||||
|
|
||||
| 31-01-12 |
Buy
Re: No Brainer
|
|||
|
|
||||
|
|
||||
|
great so ths means that with no dt the busness wll be about two mll quid a year more profitable with a market cap of a couple of miillon iisnt ths a good thng
|
||||
|
|
||||
They have not been approved or issued by Interactive Investor Trading Limited.
Editor's Pick:
What's in store today...Editor's Pick:
Glenstrata's just a silly word. Stick to big dividendsEditor's Pick:
Bulls should head for ChinaEditor's Pick:
Stock to Watch: Imperial TobaccoEditor's Pick:
George Godber’s AIM stock picks

